CNBX PHARMACEUTICALS INC. Other Nonoperating Expense
CNBX PHARMACEUTICALS INC. (CNBX) reported Other Nonoperating Expense of $42.28 thousand for the 12-month period ending 2025-08-31, per its 10-K filed 2025-12-01.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2025-12-01
- CNBX PHARMACEUTICALS INC. other nonoperating expense for the quarter ending 2022-08-31 was $14.15K, a 83.31% decline year-over-year.
- CNBX PHARMACEUTICALS INC. other nonoperating expense for the quarter ending 2022-05-31 was $46.65K, a 92.80% decline year-over-year.
- CNBX PHARMACEUTICALS INC. other nonoperating expense for the quarter ending 2022-02-28 was $508.61K, a 709.19% increase year-over-year.
- CNBX PHARMACEUTICALS INC. other nonoperating expense for the quarter ending 2021-11-30 was $212.67K.
- CNBX PHARMACEUTICALS INC. other nonoperating expense for fiscal 2025 was $42.28K, a 82.86% increase from fiscal 2024.
- CNBX PHARMACEUTICALS INC. other nonoperating expense for fiscal 2024 was $23.12K.
- CNBX PHARMACEUTICALS INC. other nonoperating expense for fiscal 2022 was $782.08K, a 1.03% decline from fiscal 2021.
- CNBX PHARMACEUTICALS INC. other nonoperating expense for fiscal 2021 was $790.24K.
| Period end | Other Nonoperating Expense 3 month | Other Nonoperating Expense 6 month | Other Nonoperating Expense 9 month | Other Nonoperating Expense 12 month |
|---|---|---|---|---|
| 2025-08-31 | $42.28K 10-K · filed 2025-12-01 | |||
| 2024-08-31 | $23.12K 10-K · filed 2025-12-01 | |||
| 2022-08-31 | $14.15K derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-30 | $60.80K derived: sum of 2 quarters · filed 2022-11-30 | $569.41K derived: sum of 3 quarters · filed 2022-11-30 | $782.08K 10-K · filed 2022-11-30 |
| 2022-05-31 | $46.65K 10-Q · filed 2022-07-14 | $555.26K derived: sum of 2 quarters · filed 2022-07-14 | $767.93K 10-Q · filed 2022-07-14 | $852.75K derived: sum of 4 quarters · filed 2022-11-30 |
| 2022-02-28 | $508.61K 10-Q · filed 2022-04-12 | $721.28K 10-Q · filed 2022-04-12 | $806.11K derived: sum of 3 quarters · filed 2022-11-30 | $1.45M derived: sum of 4 quarters · filed 2022-11-30 |
| 2021-11-30 | $212.67K derived: 10-K 12 month − 3 quarters · filed 2022-11-30 | $297.50K derived: sum of 2 quarters · filed 2022-11-30 | $945.02K derived: sum of 3 quarters · filed 2022-11-30 | $1.01M derived: sum of 4 quarters · filed 2022-11-30 |
| 2021-08-31 | $84.83K derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-30 | $732.35K derived: sum of 2 quarters · filed 2022-11-30 | $795.20K derived: sum of 3 quarters · filed 2022-11-30 | $790.24K 10-K · filed 2022-11-30 |
| 2021-05-31 | $647.52K 10-Q · filed 2022-07-14 | $710.38K derived: sum of 2 quarters · filed 2022-07-14 | $705.41K 10-Q · filed 2022-07-14 | |
| 2021-02-28 | $62.85K 10-Q · filed 2022-04-12 | $57.89K 10-Q · filed 2022-04-12 |